Login / Signup

Viral isolation allows characterization of early samples of SARS-CoV-2 lineage B1.1.33 with unique mutations (S: H655Y and T63N) circulating in Southern Brazil in 2020.

Juliana Schons GularteMariana Soares da SilvaMicheli FilippiMeriane DemolinerKaroline SchallenbergerAlana Witt HansenVyctoria Malayhka de Abreu Góes PereiraFágner Henrique HeldtViviane GirardiMatheus Nunes WeberPaula Rodrigues de AlmeidaBruno Lopes AbbadiMaiele DornellesCristiano Valim BizarroPablo MachadoLuiz Augusto BassoOdir Antonio DellagostinJuliane Deise FleckFernando Rosado Spilki
Published in: Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] (2022)
Different approaches are in use to improve our knowledge about the causative agent of coronavirus disease (COVID-19). Cell culture-based methods are the better way to perform viral isolation, evaluate viral infectivity, and amplify the virus. Furthermore, next-generation sequencing (NGS) have been essential to analyze a complete genome and to describe new viral species and lineages that have arisen over time. Four naso-oropharyngeal swab samples, collected from April to July of 2020, were isolated and sequenced aiming to produce viral stocks and analyze the mutational profile of the found lineage. B.1.1.33 was the lineage detected in all sequences. Although the samples belong to the same lineage, it was possible to evaluate different mutations found including some that were first described in these sequences, like the S:H655Y and T63N. The results described here can help to elicit how the pandemic started to spread and how it has been evolving in south Brazil.
Keyphrases
  • sars cov
  • coronavirus disease
  • respiratory syndrome coronavirus
  • single cell
  • healthcare
  • cell fate
  • genome wide
  • copy number
  • circulating tumor